BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO CANCER IMMUNOTHERAPEUTIC AGENT AND… Application WO-2022103242-A1 World Intellectual Property Organisation (WIPO) 19 May 2022